Postcesarean epidural morphine: a dose-response study.

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Postcesarean delivery pain management is crucial for maternal recovery.
• Epidural analgesia is a common method for managing labor and delivery pain.
• Optimizing epidural morphine dosage is essential for effective pain relief and minimizing side effects.

Purpose of the Study:

• To determine the dose-response relationship of epidural morphine for postcesarean analgesia.
• To evaluate the association between epidural morphine dose and side effects such as pruritus, nausea, and vomiting.
• To identify optimal dosing strategies for postcesarean pain management.

Main Methods:

• A randomized controlled trial involving 60 parturients undergoing cesarean delivery.
• Administration of single doses of epidural morphine (0, 1.25, 2.5, 3.75, or 5 mg).
• Use of patient-controlled analgesia (PCA) for supplemental pain relief, with PCA morphine use and side effects recorded over 24 hours.

Main Results:

• Patient-controlled analgesia (PCA) morphine use decreased significantly with increasing epidural morphine doses (2.5-5 mg) compared to placebo.
• Pruritus scores were significantly higher in all epidural morphine groups compared to the control group, but not dose-dependent among treatment groups.
• No significant relationship was found between epidural morphine dose and the incidence or severity of nausea and vomiting.

Conclusions:

• Analgesic quality improves with epidural morphine doses up to 3.75 mg, with no additional benefit at 5 mg.
• Side effects, including pruritus, were not dose-related within the tested range.
• Optimal postcesarean analgesia may require augmenting epidural morphine with other analgesic modalities.